Clinical Trial Update: Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous peripheral blood stem cell transplant for germ cell tumors (childhood germ cell tumor and ovarian cancer) has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Germ Cell Tumor
• Ovarian Cancer
• Teratoma

Drugs mentioned

• Autologous peripheral blood stem cell transplantation

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Childhood Germ Cell Tumor, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-05-17